QUIDELORTHO CORP (QDEL) Stock Fundamental Analysis
NASDAQ:QDEL - Nasdaq - US2197981051 - Common Stock - Currency: USD
We assign a fundamental rating of 3 out of 10 to QDEL. QDEL was compared to 191 industry peers in the Health Care Equipment & Supplies industry. QDEL has a bad profitability rating. Also its financial health evaluation is rather negative. QDEL may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year QDEL was profitable.
In the past year QDEL had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: QDEL reported negative net income in multiple years.
QDEL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
QDEL's Return On Assets of -31.94% is in line compared to the rest of the industry. QDEL outperforms 42.93% of its industry peers.
The Return On Equity of QDEL (-68.76%) is comparable to the rest of the industry.
The Return On Invested Capital of QDEL (0.67%) is better than 67.54% of its industry peers.
The Average Return On Invested Capital over the past 3 years for QDEL is below the industry average of 7.68%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -68.76% | ||
| ROIC | 0.67% |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
1.3 Margins
Looking at the Operating Margin, with a value of 1.65%, QDEL is in the better half of the industry, outperforming 67.54% of the companies in the same industry.
QDEL's Operating Margin has declined in the last couple of years.
QDEL has a worse Gross Margin (46.23%) than 61.26% of its industry peers.
QDEL's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 46.23% |
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
2. Health
2.1 Basic Checks
QDEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for QDEL has been increased compared to 1 year ago.
The number of shares outstanding for QDEL has been increased compared to 5 years ago.
QDEL has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.82, we must say that QDEL is in the distress zone and has some risk of bankruptcy.
QDEL has a Altman-Z score (0.82) which is in line with its industry peers.
A Debt/Equity ratio of 0.72 indicates that QDEL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.72, QDEL is not doing good in the industry: 68.59% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.82 |
ROIC/WACC0.07
WACC9.32%
2.3 Liquidity
QDEL has a Current Ratio of 1.22. This is a normal value and indicates that QDEL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of QDEL (1.22) is worse than 81.15% of its industry peers.
A Quick Ratio of 0.69 indicates that QDEL may have some problems paying its short term obligations.
QDEL has a worse Quick ratio (0.69) than 86.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
QDEL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.21%.
QDEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.03% yearly.
QDEL shows a decrease in Revenue. In the last year, the revenue decreased by -7.17%.
QDEL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.07% yearly.
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%
3.2 Future
QDEL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 28.34% yearly.
QDEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.57% yearly.
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue Next Year-2.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.2%
Revenue Next 5Y2.57%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 13.28, which indicates a correct valuation of QDEL.
Based on the Price/Earnings ratio, QDEL is valued cheaply inside the industry as 88.48% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. QDEL is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.22, the valuation of QDEL can be described as reasonable.
Based on the Price/Forward Earnings ratio, QDEL is valued cheaper than 94.24% of the companies in the same industry.
QDEL is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.32, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.28 | ||
| Fwd PE | 10.22 |
4.2 Price Multiples
QDEL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QDEL is cheaper than 93.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.18 |
4.3 Compensation for Growth
QDEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
QDEL's earnings are expected to grow with 33.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y34.34%
EPS Next 3Y33.27%
5. Dividend
5.1 Amount
QDEL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.56
-0.61 (-2.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.74%
Inst Owner Change0.56%
Ins Owners0.49%
Ins Owner Change0.41%
Market Cap1.66B
Analysts76
Price Target54.5 (121.91%)
Short Float %6.42%
Short Ratio4.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)83.37%
Min EPS beat(2)4.59%
Max EPS beat(2)162.15%
EPS beat(4)4
Avg EPS beat(4)61.93%
Min EPS beat(4)4.59%
Max EPS beat(4)162.15%
EPS beat(8)6
Avg EPS beat(8)32.62%
EPS beat(12)9
Avg EPS beat(12)35.38%
EPS beat(16)11
Avg EPS beat(16)28.34%
Revenue beat(2)1
Avg Revenue beat(2)5.13%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)11.02%
Revenue beat(4)3
Avg Revenue beat(4)3.15%
Min Revenue beat(4)-0.75%
Max Revenue beat(4)11.02%
Revenue beat(8)6
Avg Revenue beat(8)1.91%
Revenue beat(12)9
Avg Revenue beat(12)2.77%
Revenue beat(16)11
Avg Revenue beat(16)4.19%
PT rev (1m)0%
PT rev (3m)0.54%
EPS NQ rev (1m)-5.8%
EPS NQ rev (3m)-9.85%
EPS NY rev (1m)-1.57%
EPS NY rev (3m)-4.78%
Revenue NQ rev (1m)-1.09%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)-3.19%
Revenue NY rev (3m)-2.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.28 | ||
| Fwd PE | 10.22 | ||
| P/S | 0.6 | ||
| P/FCF | N/A | ||
| P/OCF | 19.96 | ||
| P/B | 0.56 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.18 |
EPS(TTM)1.85
EY7.53%
EPS(NY)2.4
Fwd EY9.79%
FCF(TTM)-1.66
FCFYN/A
OCF(TTM)1.23
OCFY5.01%
SpS41.26
BVpS44.25
TBVpS-5.94
PEG (NY)0.44
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.94% | ||
| ROE | -68.76% | ||
| ROCE | 0.84% | ||
| ROIC | 0.67% | ||
| ROICexc | 0.68% | ||
| ROICexgc | 1.86% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 46.23% | ||
| FCFM | N/A |
ROA(3y)-8.62%
ROA(5y)9.28%
ROE(3y)-19.28%
ROE(5y)7.89%
ROIC(3y)4.37%
ROIC(5y)20.45%
ROICexc(3y)4.54%
ROICexc(5y)30.14%
ROICexgc(3y)17.29%
ROICexgc(5y)56.29%
ROCE(3y)5.53%
ROCE(5y)25.88%
ROICexcg growth 3Y-72.1%
ROICexcg growth 5Y-43.85%
ROICexc growth 3Y-77.1%
ROICexc growth 5Y-42.97%
OM growth 3Y-68.75%
OM growth 5Y-39.02%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.83%
GM growth 5Y-5.07%
F-Score3
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.72 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.29 | ||
| Cap/Depr | 43.03% | ||
| Cap/Sales | 7.01% | ||
| Interest Coverage | 0.26 | ||
| Cash Conversion | 16.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.82 |
F-Score3
WACC9.32%
ROIC/WACC0.07
Cap/Depr(3y)46.16%
Cap/Depr(5y)161.74%
Cap/Sales(3y)6.1%
Cap/Sales(5y)7.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.21%
EPS 3Y-52.97%
EPS 5Y-9.03%
EPS Q2Q%-46.15%
EPS Next Y29.93%
EPS Next 2Y34.34%
EPS Next 3Y33.27%
EPS Next 5Y28.34%
Revenue 1Y (TTM)-7.17%
Revenue growth 3Y17.89%
Revenue growth 5Y39.07%
Sales Q2Q%-4.69%
Revenue Next Year-2.37%
Revenue Next 2Y0.91%
Revenue Next 3Y2.2%
Revenue Next 5Y2.57%
EBIT growth 1Y-81.86%
EBIT growth 3Y-63.16%
EBIT growth 5Y-15.19%
EBIT Next Year935.81%
EBIT Next 3Y135.12%
EBIT Next 5Y92.11%
FCF growth 1Y-258.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.38%
OCF growth 3Y-53.13%
OCF growth 5Y-9.2%